We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Cancer Genetics, AstraZeneca Announce Biomarker and MDx Partnership

News   Jun 10, 2014

 
Cancer Genetics, AstraZeneca Announce Biomarker and MDx Partnership
 
 
 

RELATED ARTICLES

Tuberculosis Tests are Inadequate, Better Options Identified

News

Rapid blood tests used by the NHS are unable to rule out tuberculosis (TB) and should be replaced with a new, more accurate test, a study has found.

READ MORE

‘Shortcut’ Transforms Terpene Biosynthesis in E. Coli

News

Researchers have developed an artificial enzymatic pathway for synthesizing isoprenoids, or terpenes, in E. coli. This shorter, more efficient, cost-effective and customizable pathway transforms E. coli into a factory that can produce terpenes for use in everything from cancer drugs to biofuels.

READ MORE

AI-enabled UTI Detection to Reduce Preventable Hospital Admissions

News

New AI developed at the University of Surrey could identify and help reduce one of the top causes of hospitalisation for people living with dementia - urinary tract infections (UTI).

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Diagnostics Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE